June 8, 2005 — The U.S. Food and Drug Administration (FDA) approved in March revisions to safety labeling to advise that use of rosuvastatin calcium tablets is associated with an increased risk of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback